TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹63.92 | ₹56.47 | ₹48.94 | ₹36.79 | ₹22.96 |
What is the latest Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹63.92 |
| Mar2025 | ₹56.47 |
| Mar2024 | ₹48.94 |
| Mar2023 | ₹36.79 |
| Mar2022 | ₹22.96 |
How is Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹63.92 | 13.19 | |
| Mar2025 | ₹56.47 | 15.39 | |
| Mar2024 | ₹48.94 | 33.03 | |
| Mar2023 | ₹36.79 | 60.24 | |
| Mar2022 | ₹22.96 | - | |
Compare Earnings Per Share (EPS) of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹179,168.4 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,049.0 Cr | -0.4% | 7.1% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.9% |
-2.9% |
32.7% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses